1327 related articles for article (PubMed ID: 16554261)
21. Therapeutic strategies for the treatment of spinal muscular atrophy.
Cherry JJ; Androphy EJ
Future Med Chem; 2012 Sep; 4(13):1733-50. PubMed ID: 22924510
[TBL] [Abstract][Full Text] [Related]
22. Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cells.
Angelozzi C; Borgo F; Tiziano FD; Martella A; Neri G; Brahe C
J Med Genet; 2008 Jan; 45(1):29-31. PubMed ID: 17932121
[TBL] [Abstract][Full Text] [Related]
23. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
[TBL] [Abstract][Full Text] [Related]
24. Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs.
Madocsai C; Lim SR; Geib T; Lam BJ; Hertel KJ
Mol Ther; 2005 Dec; 12(6):1013-22. PubMed ID: 16226920
[TBL] [Abstract][Full Text] [Related]
25. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the role of SMN1 and SMN2 haploinsufficiency as a risk factor for Hirayama's disease: clinical, neurophysiological and genetic characteristics in a Spanish series of 13 patients.
Gamez J; Also E; Alias L; Corbera-Bellalta M; Barceló MJ; Centeno M; Raguer N; Gratacós M; Baiget M; Tizzano EF
Clin Neurol Neurosurg; 2007 Dec; 109(10):844-8. PubMed ID: 17850955
[TBL] [Abstract][Full Text] [Related]
27. Genotype-phenotype correlation of SMN locus genes in spinal muscular atrophy patients from India.
Kesari A; Idris MM; Chandak GR; Mittal B
Exp Mol Med; 2005 Jun; 37(3):147-54. PubMed ID: 16000867
[TBL] [Abstract][Full Text] [Related]
28. Quantitative analysis of SMN1 and SMN2 genes based on DHPLC: a highly efficient and reliable carrier-screening test.
Su YN; Hung CC; Li H; Lee CN; Cheng WF; Tsao PN; Chang MC; Yu CL; Hsieh WS; Lin WL; Hsu SM
Hum Mutat; 2005 May; 25(5):460-7. PubMed ID: 15832310
[TBL] [Abstract][Full Text] [Related]
29. Spinal muscular atrophy diagnostics.
Prior TW
J Child Neurol; 2007 Aug; 22(8):952-6. PubMed ID: 17761649
[TBL] [Abstract][Full Text] [Related]
30. Spinal muscular atrophy: from animal model to clinical trial.
Zanoteli E; Maximino JR; Conti Reed U; Chadi G
Funct Neurol; 2010; 25(2):73-9. PubMed ID: 20923604
[TBL] [Abstract][Full Text] [Related]
31. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
[TBL] [Abstract][Full Text] [Related]
32. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy.
Monani UR; Sendtner M; Coovert DD; Parsons DW; Andreassi C; Le TT; Jablonka S; Schrank B; Rossoll W; Prior TW; Morris GE; Burghes AH
Hum Mol Genet; 2000 Feb; 9(3):333-9. PubMed ID: 10655541
[TBL] [Abstract][Full Text] [Related]
33. Inverse correlation between SMN1 and SMN2 copy numbers: evidence for gene conversion from SMN2 to SMN1.
Ogino S; Gao S; Leonard DG; Paessler M; Wilson RB
Eur J Hum Genet; 2003 Mar; 11(3):275-7. PubMed ID: 12673282
[TBL] [Abstract][Full Text] [Related]
34. Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease.
Monani UR
Neuron; 2005 Dec; 48(6):885-96. PubMed ID: 16364894
[TBL] [Abstract][Full Text] [Related]
35. Valproic acid increases the SMN2 protein level: a well-known drug as a potential therapy for spinal muscular atrophy.
Brichta L; Hofmann Y; Hahnen E; Siebzehnrubl FA; Raschke H; Blumcke I; Eyupoglu IY; Wirth B
Hum Mol Genet; 2003 Oct; 12(19):2481-9. PubMed ID: 12915451
[TBL] [Abstract][Full Text] [Related]
36. Spinal muscular atrophy carrier screening by multiplex polymerase chain reaction using dried blood spot on filter paper.
Majumdar R; Rehana Z; Al Jumah M; Fetaini N
Ann Hum Genet; 2005 Mar; 69(Pt 2):216-21. PubMed ID: 15720302
[TBL] [Abstract][Full Text] [Related]
37. The effect of hydroxyurea in spinal muscular atrophy cells and patients.
Liang WC; Yuo CY; Chang JG; Chen YC; Chang YF; Wang HY; Ju YH; Chiou SS; Jong YJ
J Neurol Sci; 2008 May; 268(1-2):87-94. PubMed ID: 18166199
[TBL] [Abstract][Full Text] [Related]
38. Restoration of SMN function: delivery of a trans-splicing RNA re-directs SMN2 pre-mRNA splicing.
Coady TH; Shababi M; Tullis GE; Lorson CL
Mol Ther; 2007 Aug; 15(8):1471-8. PubMed ID: 17551501
[TBL] [Abstract][Full Text] [Related]
39. [The expression of SMN2 gene mRNA in neuron-like cells derived from patients with spinal muscular atrophy].
Luo XM; Yang XS; Xiao B
Zhonghua Nei Ke Za Zhi; 2006 Oct; 45(10):831-4. PubMed ID: 17217749
[TBL] [Abstract][Full Text] [Related]
40. Multiplex ligation-dependent probe amplification improves diagnostics in spinal muscular atrophy.
Arkblad EL; Darin N; Berg K; Kimber E; Brandberg G; Lindberg C; Holmberg E; Tulinius M; Nordling M
Neuromuscul Disord; 2006 Dec; 16(12):830-8. PubMed ID: 17049859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]